Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

SOLS vs ALB: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

ALB Wins Head-to-Head Institutional Verdict (3–3 across 6 Pillars · 7–2 Matrix Metrics)

ALB Overall Winner 6-Pillar Tally: SOLS 3 – 3 ALB Matrix Metrics: SOLS 2 – 7 ALB

As of Nov 16, 2026, Albemarle Corporation (ALB) is the stronger overall head-to-head candidate over Solstice Advanced Materials Inc. (SOLS) in the Tradestie Institutional Equity Comparison Engine, winning 7–2 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Balance Sheet & Cash Flow). SOLS carries a Unified Composite Score of 34.5/100 (SELL) at $64.60 (19.6x Forward P/E, 17.2% operating margin), whereas ALB carries 57.8/100 (HOLD) at $88.41 (11.1x Forward P/E, 17.1% operating margin).

  • Technical & Structure Timing Caution: SOLS is currently in a Breakdown options structure phase (RSI 55.8); meanwhile ALB is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 34.7). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About SOLS vs ALB
SOLS US Equity
Solstice Advanced Materials Inc.
Chemicals & Allied Products
$64.60
-2.3% 1D
Market Cap $10.5B
TTM Revenue $4.17B
Forward P/E 19.6x
Beta / 30D Vol 1.66β · 67% Vol
Unified Composite Score
34.5 / 100 SELL
Tech 8.0 Fund 31.0 Flow 58.0 Mom 31.4
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (1.4% over 20 days), RSI 56
RSI-14: 55.8 · SMA20: $62.07 · SMA50: $60.31
ALB NYSE Head-to-Head Winner
Albemarle Corporation
Plastic Materials, Synth Resins & Nonvulcan Elastomers
$88.41
-5.47% 1D
Market Cap $11.2B
TTM Revenue $4.42B
Forward P/E 11.1x
Beta / 30D Vol 0.94β · 44% Vol
Unified Composite Score
57.8 / 100 HOLD
Tech 37.0 Fund 53.0 Flow 58.0 Mom 64.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -13.4%), weak momentum, RSI 35
RSI-14: 34.7 · SMA20: $94.53 · SMA50: $102.81

6-Pillar Scorecard Institutional Category Breakdown (SOLS 3 – 3 ALB)

Columns: Metric · SOLS · ALB
1. Valuation Multiples ALB
Forward P/E 19.6x 11.1x
Trailing P/E 32.6x 22.9x
PEG Ratio 0.40x 0.79x
EV / Revenue 2.9x 2.5x
2. Growth & Scale ALB
Revenue Growth (YoY) +7.9% +18.8%
Earnings Growth (YoY) +22.8% -66.2%
TTM Revenue (USD) $4.17B $4.42B
Market Cap $10.5B $11.2B
3. Profitability & Quality SOLS
Gross Margin 30.9% 26.2%
Operating Margin 17.2% 17.1%
Net Profit Margin 7.8% 11.1%
Return on Equity (ROE) 16.0% 7.0%
4. Balance Sheet & Cash Flow ALB
Cash Generation (TTM) $427M $1.04B
Cash Flow Margin 10.2% 23.5%
Net Cash / Leverage $1.70B Net Debt (1.55x D/E) $25M Net Debt (0.18x D/E)
Dividend Yield 0.34% 1.69%
5. Options & Positioning SOLS
Options Structure Phase BREAKDOWN BREAKDOWN
Current IV / %ile 46.8% (6th %ile) 59.5% (26th %ile)
Put/Call OI Skew 0.11x (Call-Skewed) 0.53x (Call-Skewed)
OBV Trend / Tech Phase ACCUMULATION · Markup NEUTRAL · Markdown
6. R&D & Supply-Chain Moat SOLS
OpEx & R&D Intensity 13.7% of Rev ($572M) 9.1% of Rev ($402M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Scale & Operating Efficiency Moat Scale & Operating Efficiency Moat
Supply-Chain Role Specialty Chemicals Operator Specialty Chemicals Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: SOLS (2) vs ALB (7)
Institutional Metric SOLS ALB Criterion Row Edge
Market Capitalization
Scale
$10.5B $11.2B Larger Scale ALB
Trailing P/E Ratio
Valuation
32.6x 22.9x Lower Multiple ALB
Forward P/E Ratio
Valuation
19.6x 11.1x Lower Multiple ALB
Revenue Growth (YoY)
Growth
+7.9% +18.8% Higher Growth ALB
Operating Margin (TTM)
Profitability
17.2% 17.1% Higher Margin Tie
Net Profit Margin
Profitability
7.8% 11.1% Higher Margin ALB
Return on Equity (ROE)
Capital Efficiency
16.0% 7.0% Higher ROE SOLS
52-Week Range Position
Momentum
48% ($40–$91) 0% ($88–$221) Stronger Trend SOLS
Beta / 30D Volatility
Risk Regime
1.66β · 67% Vol 0.94β · 44% Vol Lower Realized Risk ALB
Unified Institutional Score
Composite Signal
34.5 / 100 (SELL) 57.8 / 100 (HOLD) Higher Composite ALB
Trailing 12M Revenue (USD)
Operating Scale
$4.17B $4.42B FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
30.9% 26.2% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
0.40x PEG · 2.9x EV/Rev 0.79x PEG · 2.5x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$427M ($1.70B Net Debt (1.55x D/E)) $1.04B ($25M Net Debt (0.18x D/E)) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon SOLS +16.43 pp
SOLS: +9.03% · ALB: -7.4%
3M Horizon SOLS +40.89 pp
SOLS: +7.51% · ALB: -33.38%
6M Horizon SOLS +28.4 pp
SOLS: -21.29% · ALB: -49.69%
1Y Horizon SOLS +64.09 pp
SOLS: +41.26% · ALB: -22.83%

Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant USD Revenue & Operating Margin (%)
Period SOLS Revenue ALB Revenue SOLS Op. Margin ALB Op. Margin Margin Leader
FY2018 N/A $3.37B N/A 27.0% ALB
FY2019 N/A $3.59B N/A 18.6% ALB
FY2020 N/A $3.13B N/A 16.2% ALB
FY2021 N/A $3.33B N/A 24.0% ALB
FY2022 N/A $7.32B N/A 33.7% ALB
FY2023 $3.65B $9.62B 17.0% 2.6% SOLS
FY2024 $3.77B $5.38B 15.8% -33.0% SOLS
FY2025 $3.89B $5.14B 6.1% -7.1% SOLS

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
SOLS BREAKDOWN
129d in phase · OBV ACCUMULATION
Current IV 46.8%
IV Percentile 6th %ile
Put/Call OI Skew 0.11x (Call-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow ACCUMULATION
Exact SOLS Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
ALB BREAKDOWN
148d in phase · OBV NEUTRAL
Current IV 59.5%
IV Percentile 26th %ile
Put/Call OI Skew 0.53x (Call-Skewed)
IV Regime Balanced (25th–60th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact ALB Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
SOLS Moat Profile Scale & Operating Efficiency Moat
Specialty Chemicals Operator
Competes within the Specialty Chemicals value chain with $10.5B market capitalization and 17.2% operating margin.
OpEx & R&D Reinvestment 13.7% of Rev ($572M)
90D Engineering Disclosures 0 Published
ALB Moat Profile Scale & Operating Efficiency Moat
Specialty Chemicals Operator
Competes within the Specialty Chemicals value chain with $11.2B market capitalization and 17.1% operating margin.
OpEx & R&D Reinvestment 9.1% of Rev ($402M)
90D Engineering Disclosures 0 Published

Investor FAQ SOLS vs ALB Key Questions & Quantitative Answers

As of Nov 16, 2026, Albemarle Corporation (ALB) is the stronger overall head-to-head candidate over Solstice Advanced Materials Inc. (SOLS) in the Tradestie Institutional Equity Comparison Engine, winning 7–2 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Balance Sheet & Cash Flow). SOLS carries a Unified Composite Score of 34.5/100 (SELL) at $64.60 (19.6x Forward P/E, 17.2% operating margin), whereas ALB carries 57.8/100 (HOLD) at $88.41 (11.1x Forward P/E, 17.1% operating margin). Technical & Structure Timing Caution: SOLS is currently in a Breakdown options structure phase (RSI 55.8); meanwhile ALB is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 34.7). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

ALB leads the Growth & Scale pillar: SOLS posts +7.9% YoY revenue growth and +22.8% YoY earnings growth on $4.17B TTM revenue (30.9% gross margin, 17.2% operating margin), compared with ALB at +18.8% YoY revenue growth and -66.2% YoY earnings growth on $4.42B TTM revenue (26.2% gross margin, 17.1% operating margin). Across the 8-period historical trajectory (FY2018 to FY2025), SOLS cumulative revenue shifted +6.6% while ALB shifted +52.5%. In operating R&D and SG&A reinvestment, SOLS deploys 13.7% of Rev ($572M) (0 90-day corporate R&D disclosures) versus 9.1% of Rev ($402M) (0 disclosures) for ALB.

ALB screens cheaper on headline valuation multiples. SOLS trades at 19.6x Forward P/E, 32.6x Trailing P/E, 0.40x PEG, and 2.9x EV/Revenue (10.2% FCF margin), whereas ALB trades at 11.1x Forward P/E, 22.9x Trailing P/E, 0.79x PEG, and 2.5x EV/Revenue (23.5% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against SOLS (16.0% ROE) versus ALB (7.0% ROE) capital efficiency.

In options market volatility and institutional positioning, SOLS carries 46.8% implied volatility (6th %ile, Compressed (<25th %ile)), a 0.11x (Call-Skewed) Put/Call open-interest ratio, ACCUMULATION on-balance volume, and sits in a BREAKDOWN options structure phase (1.66β · 67% Vol realized risk). By comparison, ALB carries 59.5% implied volatility (26th %ile, Balanced (25th–60th %ile)), a 0.53x (Call-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in a BREAKDOWN options structure phase (0.94β · 44% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.